Literature DB >> 2192414

Early intervention with recombinant human erythropoietin therapy.

B P Teehan1, R L Benz, M H Sigler, J M Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192414

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


× No keyword cloud information.
  6 in total

Review 1.  Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients.

Authors:  Deirdre Hahn; Christopher I Esezobor; Noha Elserafy; Angela C Webster; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2017-01-09

2.  A randomized controlled study comparing once-weekly to every-2-week and every-4-week dosing of epoetin alfa in CKD patients with anemia.

Authors:  Pablo E Pergola; Gary Gartenberg; Min Fu; Steven Sun; Marsha Wolfson; Peter Bowers
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

Review 3.  Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?

Authors:  Farhanah Yousaf; Bruce Spinowitz
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 4.  Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis.

Authors:  June D Cody; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2016-01-20

5.  A randomized controlled study of weekly and biweekly dosing of epoetin alfa in CKD Patients with anemia.

Authors:  Pablo E Pergola; Gary Gartenberg; Min Fu; Marsha Wolfson; Sudhakar Rao; Peter Bowers
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 8.237

Review 6.  Hemoglobin targets for chronic kidney disease patients with anemia: a systematic review and meta-analysis.

Authors:  Zhou Jing; Yuan Wei-jie; Zhu Nan; Zhou Yi; Wang Ling
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.